prescription drug
-
The Future of Medicare Drug Price Negotiation and Pharmaceutical Innovation
•
One of the most publicized provisions of the Inflation Reduction Act (IRA) is the section mandating that a small subset of the most expensive pharmaceutical products in the U.S. be subject to Medicare price negotiations. The provision applies only to a minority of branded drugs and the implementation of it…
-
The Insidious Relationship between Pharmaceutical Marketing to Physicians, Opioid Prescriptions, and Overdose Deaths
•
In 2017, as opioid-related deaths surpassed deaths from car accidents and gun homicides combined, the Trump Administration declared the opioid crisis a public health emergency. Since then, policymakers have responded with solutions ranging from pharmacological remedies to prescription drug monitoring programs; however, there has been little accountability of those who…
-
Preventing Opioid Abuse Through Mandatory Prescription Drug Monitoring Programs
•
A new study suggests that mandatory physician-led monitoring of opioid prescriptions may be an important tool in the effort to combat opioid abuse. The opioid epidemic is an increasingly serious problem in the United States, with over 50,000 people killed by opioid overdoses in 2017. President Trump declared the crisis…
-
Medicare Part D Plans: The more the merrier?
•
Recent research finds little evidence of choice overload in the Medicare Part D Plan market.
-
Swallowing a Bitter Pill: Expensive Prescriptions Mean Low Adherence
•
Low-income patients benefit when physicians prescribe cheaper drugs, but physicians don’t always know how much patients pay.